Author

Stefanie Höfer

Technical University of MunichORCID 0009-0006-0489-6854Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Amirhossein SakhtemaniD· 2 shared Bernhard KüsteriD· 2 shared Firas HamoodiD· 2 shared Florian P BayeriD· 2 shared Jens Thomas SivekeiD· 2 shared Matthew TheiD· 2 shared Albrecht StenzingeriD· 1 shared Alexander ToliosiD· 1 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Amirhossein SakhtemanORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 9, 2026

Prospective pan-cancer phosphoproteomics at clinical scale extends therapeutic options in precision oncology

Annika Schneider, Julia Wortmann, Cecilia Bang Jensen…·Bernhard Küster

This study uses pan-cancer phosphoproteomics to identify therapeutic targets and improve precision oncology by analyzing 1,998 tumor samples and developing new scores for kinase activity and immune response.

DOI 10.64898/2026.07.08.737171

humanproteomics

𝕏 PostBluesky

Cancer BiologyMolecular Systems BiologyPeer-reviewedJan 21, 2025

Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response

Stefanie Höfer, Larissa Frasch, Sarah Brajkovic…·Bernhard Küster

This study identifies ATR inhibitors as synergistic with gemcitabine in killing PDAC cells by blocking the DNA damage response pathway.

31 citationstop 1%

humanproteomics

𝕏 PostBluesky

GeneticsbioRxivPreprintDec 21, 2018

Diagnostic high-throughput sequencing of 2,390 patients with bleeding, thrombotic and platelet disorders

Kate Downes, Karyn Mégy, Daniel Duarte…·Kathleen Freson

The paper reports a diagnostic HTS test for bleeding, thrombotic, and platelet disorders, identifying molecular diagnoses in 897 out of 2,390 patients.

DOI 10.1101/504142

humanwhole-exome sequencing

𝕏 PostBluesky